The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes

被引:13
作者
Cuculi, F. [1 ]
Radovanovic, D. [1 ]
Eberli, F. R. [1 ]
Stauffer, J. C. [1 ]
Bertel, O. [1 ]
Erne, P. [1 ]
机构
[1] Kantonsspital Luzern, Dept Cardiol, CH-6000 Luzern, Switzerland
关键词
acute coronary syndromes; statin therapy; presentation mode; AMIS project;
D O I
10.1159/000106676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The role of statin use in the treatment of acute coronary syndromes (ACS) is not clear. The aim of our study was to evaluate the role of statins in ACS. Methods: Using data from the Acute Myocardial Infarction in Switzerland (AMIS Plus) Project, we compared the effects of chronic statin use, statin therapy after admission and no statin therapy on presentation mode and outcomes in ACS. Results: Available data from the period 2001-2006 including 11,603 patients were analyzed. Major cardiac event rates and in-hospital mortality were more common in statin-naive patients compared to patients who received statins. Conclusions: Our results support the importance of statin treatment in ACS. Chronic statin therapy seems to alter the initial presentation of ACS but it is questionable whether it provides an additional effect on early outcomes compared to the establishment of statin therapy after admission in statin-naive patients.
引用
收藏
页码:156 / 162
页数:7
相关论文
共 23 条
  • [1] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
    Albert, MA
    Danielson, E
    Rifai, N
    Ridker, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70
  • [2] Vascular viewpoint - Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Law MR, Wald NJ, Rudnicka AR. BMJ 2003; 326: 1407-408.
    Anand, SS
    [J]. VASCULAR MEDICINE, 2003, 8 (04) : 289 - 290
  • [3] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    Baigent, C
    Keech, A
    Kearney, PM
    Blackwell, L
    Buck, G
    Pollicino, C
    Kirby, A
    Sourjina, T
    Peto, R
    Collins, R
    Simes, J
    [J]. LANCET, 2005, 366 (9493) : 1267 - 1278
  • [4] Effects of statins on nonlipid serum markers associated with cardiovascular disease - A systematic review
    Balk, EM
    Lau, J
    Goudas, LC
    Jordan, HS
    Kupelnick, B
    Kim, LU
    Karas, RH
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (08) : 670 - 682
  • [5] Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes - A meta-analysis of randomized controlled trials
    Briel, M
    Schwartz, GG
    Thompson, PL
    de Lemos, JA
    Blazing, MA
    van Es, GA
    Kayikcioglu, M
    Arntz, HR
    den Hartog, FR
    Veeger, NJGM
    Colivicchi, F
    Dupuis, J
    Okazaki, S
    Wright, RS
    Bucher, HC
    Nordmann, AJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (17): : 2046 - 2056
  • [6] Intensive versus moderate lipid lowering with statins after acute coronary syndromes
    Cannon, CP
    Braunwald, E
    McCabe, CH
    Rader, DJ
    Rouleau, JL
    Belder, R
    Joyal, SV
    Hill, KA
    Pfeffer, MA
    Skene, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) : 1495 - 1504
  • [7] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [8] Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial
    de Lemos, JA
    Blazing, MA
    Wiviott, SD
    Lewis, EF
    Fox, KAA
    White, HD
    Rouleau, JL
    Pedersen, TR
    Gardner, LH
    Mukherjee, R
    Ramsey, KE
    Palmisano, J
    Bilheimer, DW
    Pfeffer, MA
    Califf, RM
    Braunwald, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11): : 1307 - 1316
  • [9] Erne Paul, 2003, HeartDrug, V3, P134, DOI 10.1159/000073838
  • [10] Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry
    Fassa, AA
    Urban, P
    Radovanovic, D
    Duvoisin, N
    Gaspoz, JM
    Stauffer, JC
    Erne, P
    [J]. HEART, 2005, 91 (07) : 882 - 888